Top 10 Manufacturing Capital Raises and Investors in the U.S. – July 1st – 31st, 2026
Several interesting transactions closed in the Manufacturing sector over the past month. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
PE Growth/Expansion
-
- RFI Ingredients, natural ingredients and custom blended formulas for the nutritional and dietary supplement industries, received $35 million of development capital from La Maison Partners, Astanor and Aurae Impact.
- Ascendia Pharmaceuticals, contract-development-and-manufacturing (CDMO) company dedicated to the development of enhanced formulations for pre-clinical and clinical-stage drug candidates and marketed drug products, received $4.08 million of development capital.
PIPE
-
- Replenish Nutrients Holding, an agricultural bioscience company. It manufactures and sells proprietary fertilizer products containing essential macro and micro nutrients and biological material while using a proprietary zero-waste manufacturing process, received CAD 7.5 million of development capital from SRC Agrominerals.
Buyout/LBO
-
- Obagi Cosmeceuticals, skin care products that prevents the early signs of skin aging, was acquired by Bridgepoint Group through a $460 million LBO.
Merger/Acquisition
-
- CoolIT Systems, computer hardware products for high-performance computing, cloud, and enterprise markets, was acquired by Ecolab (NYS: ECL) for $4.75 billion.
Later Stage VC
-
- Inpho, fiber optic communication equipment that supports high-speed data transmission, raised a venture funding from Cantos Ventures.
- Greenbutts, a biodegradable filter products that solves the problem of cigarette butt pollution, raised $3.24 million of venture funding.
Early Stage VC
-
- Singularity, a low-cost air defense interceptor systems that counters mass-produced aerial threats at scale, raised $80 million of Series A venture funding in a deal led by Khosla Ventures and Felicis.
- TerraFirma, a construction technology system that revolutionizes large-scale physical infrastructure, raised $100 million of Series A venture funding in a deal led by Kleiner Perkins.
Seed Round
-
- Quantum Light, a quantum pigment technology that restructures the world of pigments by creating colors, coatings, pigments, dyes, and inks, raised $2.1 million of pre-seed funding from Light Ray Ventures, Venrex Investment Management and I2BF Global Ventures.
#castleplacement #capitalraising #privateequity #venturecapital #investment #manufacturing
Rebecca Lacy
Managing Director
More than 30 years positioning companies for growth. She began her career as a retail business owner then transitioned to McDonnell Douglas/Boeing where she worked to help small businesses gain significant market share. This included advocating at the federal level for legislation to facilitate competition for small businesses. Helped businesses secure non-traditional funding through grants, as well IP and equipment donations. Served in a board or advisory capacity for several economic development organizations. Transitioned to business ownership where she and her team created diagnostic tools and training that helped companies function with greater efficiency and flexibility. Domestic and international clients ranged from start-ups to multi-national corporations from a broad array of industries, government agencies and not-for-profits. B.A. in Public Administration, MBA from Western International University. FINRA Series 7 and 63 licenses.
- Email: rlacy@castleplacement.com
- (C) (573) 880-2974
Rebecca Lacy
Managing Director
Please contact me if you have any questions or would like to discuss your capital raise:
Email: rlacy@castleplacement.com
(C) (573) 880-2974
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
